Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Interesting Posts..on this patent law firms website..many relate to the USPTO..

Interesting Posts..on this patent law firms website..many relate to the USPTO..

posted on Apr 22, 2010 01:06PM

http://tcattorney.typepad.com/patentattorneys/

one of these..which is probably old news anyway relates to this..I wonder how they figure which party is dragging their feet..in our case I hope it is more the USPTO versus on our part (i.e. applicant delay)..

01/14/2010

Patent Term Adjustment Refigured

The Federal Circuit recently rejected the USPTO’s method of calculating patent term adjustments (“PTA”) under 35 U.S.C. 154(b) in Wyeth v. Kappos No. 2009-1120 (January 7, 2010). An issued patent has a term of 20 years from the filing date of the patent application, and then it expires. 35 U.S.C. 154(b) provides for adjustment of that patent term to extend the term due to USPTO delay in examining the application, which may be decreased due to applicant delay in prosecuting the application. The Federal Circuit just rejected the USPTO’s interpretation of 35 U.S.C. 154(b)(2)(A) regarding “overlap” calculations. Accordingly, the USPTO is in the process of changing its PTA calculations. Please note that an applicant has 180 days after patent issuance to seek review of the USPTO’s PTA calculation. However, patentees should consider whether they are eligible for patent term recalculation based upon this decision.

See also Dennis Crouch Patently-O posting: Wyeth v. Kappos: Appellate Panel Confirms that PTO Is Miscalculating (Undercalculating) Delays in Prosecution and the Corresponding Patent Term Adjustment

Share
New Message
Please login to post a reply